ArticleCost effectiveness and resource allocation : C/E2026
Cost-effectiveness of early empagliflozin initiation after acute myocardial infarction: a German statutory health insurance perspective.
Priyanka Boettger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.